Construction and detection methods of characteristic spectra of kidney-nourishing and blood-tonifying granules
By constructing a characteristic spectrum of Yangshen Buxue Granules using high-performance liquid chromatography, the problem that existing detection methods cannot fully reflect the material group of Yangshen Buxue Granules is solved, and efficient and accurate evaluation of the quality of Yangshen Buxue Granules is achieved.
Patent Information
- Application Number
- CN202611530650.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-30
- Publication Date
- 2026-11-17
AI Technical Summary
Existing detection methods for kidney-nourishing and blood-tonifying granules fail to fully reflect their overall composition, resulting in significant limitations in quality control and making it difficult to achieve comprehensive quality evaluation of traditional Chinese medicine preparations.
High performance liquid chromatography (HPLC) was used to construct a characteristic chromatogram of Yangshen Buxue Granules. By using appropriate sample preparation and chromatographic detection conditions, including gradient elution program and mobile phase composition, multiple characteristic peaks in Yangshen Buxue Granules were detected, and a characteristic chromatogram was established.
It achieves a comprehensive reflection of the internal chemical composition of Yangshen Buxue Granules, with high accuracy, specificity, stability and good repeatability, and can objectively evaluate the quality of Yangshen Buxue Granules.
Smart Images

Figure CN123112293A_ABST
Abstract
Description
Technical Field
[0001] This application relates to the field of traditional Chinese medicine detection technology, and in particular to the method for constructing and detecting the characteristic spectrum of Yangshen Buxue Granules. Background Technology
[0002] Nourishing Kidney and Replenishing Blood Granules are a pure traditional Chinese medicine preparation made from pig blood extract, processed Polygonum multiflorum, wolfberry, and jujube. They have the effects of replenishing blood and benefiting the kidneys and are suitable for the adjunctive treatment of iron deficiency anemia.
[0003] The Kidney-Nourishing and Blood-Replenishing Granules are made from four herbs, resulting in a relatively complex chemical composition. Quality control of these herbs is fundamental to ensuring the effectiveness of clinical use. The preparation method of the Kidney-Nourishing and Blood-Replenishing Granules is described in published patent CN1689610A. The granules consist of pig blood extract, processed Polygonum multiflorum, Lycium barbarum, jujube extracts, sucrose, dextrin, etc. The pig blood extract is obtained by centrifuging fresh pig blood, discarding the plasma, soaking, and drying. Then, concentrated extracts of processed Polygonum multiflorum, Lycium barbarum, and jujube, along with sucrose and dextrin, are added, granulated, and dried. Based on this, the product formula was optimized by replacing sucrose with mannitol, making the medicine suitable for diabetic patients and other individuals who must avoid sugar. The dosage was also reduced from 10g / time to 5g / time, improving patient convenience and compliance. Furthermore, considering the limitations of the quality standards for the Kidney-Nourishing and Blood-Replenishing Granules, quality research was conducted.
[0004] Characteristic chromatograms of traditional Chinese medicine (TCM) are a comprehensive and quantifiable identification method that can fully reflect the types and quantities of chemical components contained in TCM and its preparations, thereby providing an overall description and evaluation of drug quality. Therefore, there is an urgent need to provide a method for constructing and detecting characteristic chromatograms for kidney-nourishing and blood-tonifying granules to better control product quality. Summary of the Invention
[0005] Based on this, one or more embodiments of this application provide a method for constructing and detecting the characteristic spectrum of Yangshen Buxue Granules. The characteristic spectrum obtained by the method of constructing the characteristic spectrum can comprehensively reflect the intrinsic chemical composition of Yangshen Buxue Granules. The detection method has high accuracy and good specificity.
[0006] One or more embodiments of this application provide a method for constructing the feature map of kidney-nourishing and blood-tonifying granules, including the following steps:
[0007] The test sample was extracted using an extraction solvent to prepare a test sample solution; the test sample was a kidney-nourishing and blood-tonifying granule; the raw materials of the kidney-nourishing and blood-tonifying granule included pig blood extract, processed Polygonum multiflorum, wolfberry, and jujube;
[0008] The test solution was subjected to high performance liquid chromatography to obtain the characteristic chromatogram of the kidney-nourishing and blood-tonifying granules;
[0009] The conditions for the high-performance liquid chromatography detection include:
[0010] Mobile phase A is acetonitrile, and mobile phase B is an aqueous solution of phosphoric acid, wherein the volume percentage of phosphoric acid in the aqueous solution is 0.08-0.12%; the flow rate is 0.85 mL / min-0.95 mL / min; gradient elution is used;
[0011] The gradient elution procedure includes:
[0012] From 0 to 25 minutes, the volume percentage of the mobile phase A is maintained at 3%.
[0013] Between 25 and 40 minutes, the volume percentage of mobile phase A increased from 3% to 11%.
[0014] From 40 min to 85 min, the volume percentage of the mobile phase A increased from 11% to 15%.
[0015] Between 85 and 110 minutes, the volume percentage of the mobile phase A increased from 15% to 18%.
[0016] In some embodiments, the conditions for high-performance liquid chromatography (HPLC) detection further include at least one of the following (1)-(3):
[0017] (1) The chromatographic column was packed with octadecylsilane-bonded silica gel;
[0018] (2) Column temperature is 25℃-35℃;
[0019] (3) The injection volume is 15 μL-25 μL;
[0020] (4) The detection wavelength is 190nm-400nm.
[0021] In some embodiments, the chromatographic column has a length of 240mm-260mm, an inner diameter of 4.5mm-4.7mm, and a packing particle size of 4μm-6μm.
[0022] In some embodiments, the weight-to-volume ratio of the kidney-nourishing and blood-tonifying granules to the extraction solvent is 2-3g:10-50mL.
[0023] In some embodiments, the extraction solvent comprises an aqueous solution of an alcohol with a volume concentration of 0%-100%;
[0024] Optionally, the alcohol includes one or more of methanol and ethanol.
[0025] In some embodiments, the step of extracting the test sample using an extraction solvent includes: mixing the test sample and the extraction solvent, and subjecting the resulting mixture to hot reflux extraction;
[0026] Optionally, the conditions for hot reflux extraction include: a heating temperature of 80℃-90℃ and a hot reflux extraction time of 20min-60min.
[0027] In some embodiments, the characteristic spectrum of the kidney-nourishing and blood-tonifying granules includes eight peaks, namely peak 1, peak 2, peak 3, peak 4, peak 5, peak 6, peak 7, and peak 8.
[0028] Among them, peak 2 is 5-hydroxymethylfurfural, peak 6 is 4-coumaric acid, peak 7 is ferulic acid, and peak 8 is 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside.
[0029] In some implementations, peak 2 is used as reference peak S1, and the relative retention times of peaks 1 and 3 with peak S1 are 0.62±10% and 1.39±10%, respectively.
[0030] With peak 8 as the reference peak S2, the relative retention times of peaks 4, 5, 6, and 7 with peak S2 are 0.46±10%, 0.47±10%, 0.72±10%, and 0.83±10%, respectively.
[0031] In some implementations, the method for constructing the feature map further includes the following steps:
[0032] A reference solution is prepared by mixing a reference standard with an organic solvent; the reference standard includes one or more of 5-hydroxymethylfurfural, 4-coumaric acid, ferulic acid, and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside.
[0033] The reference solution was subjected to high-performance liquid chromatography (HPLC) to obtain a chromatogram of the reference standard.
[0034] One or more embodiments of this application also provide a method for detecting kidney-nourishing and blood-tonifying granules, including the following steps:
[0035] The sample to be tested was extracted using an extraction solvent to prepare a solution; the sample to be tested was a kidney-nourishing and blood-tonifying granule; the raw materials of the kidney-nourishing and blood-tonifying granule included pig blood extract, processed Polygonum multiflorum, wolfberry, and jujube;
[0036] The test solution was subjected to high performance liquid chromatography to obtain a chromatogram of the test sample;
[0037] A reference solution is prepared by mixing a reference compound with an organic solvent; the reference compound includes 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside.
[0038] The reference solution was analyzed by high-performance liquid chromatography (HPLC) to obtain a reference chromatogram. The chromatograms of the test sample and the reference samples were compared. Eight characteristic peaks were observed in the test sample chromatogram. Peaks 2 and 8 corresponded to the retention times of the reference peaks 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside, respectively. The peak corresponding to the 5-hydroxymethylfurfural reference peak was designated as S. 1, Calculate the relative retention times of peaks 1 and 3 with S1. These relative retention times should be within ±10% of the specified values, which are 0.62 (peak 1) and 1.39 (peak 3). Use the peak corresponding to the reference peak of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside as S1. 2, Calculate the relative retention times of peaks 4, 5, 6, and 7 with S2. The relative retention times should be within ±10% of the specified values, which are: 0.46 (peak 4), 0.47 (peak 5), 0.72 (peak 6), and 0.83 (peak 7).
[0039] The conditions for the high-performance liquid chromatography detection include:
[0040] Mobile phase A is acetonitrile, and mobile phase B is an aqueous solution of phosphoric acid, wherein the volume percentage of phosphoric acid in the aqueous solution is 0.08-0.12%; the flow rate is 0.85 mL / min-0.95 mL / min; gradient elution is used;
[0041] The gradient elution procedure includes:
[0042] From 0 to 25 minutes, the volume percentage of the mobile phase A is maintained at 3%.
[0043] Between 25 and 40 minutes, the volume percentage of mobile phase A increased from 3% to 11%.
[0044] From 40 min to 85 min, the volume percentage of the mobile phase A increased from 11% to 15%.
[0045] Between 85 and 110 minutes, the volume percentage of the mobile phase A increased from 15% to 18%.
[0046] Compared with the prior art, this application has at least the following beneficial effects:
[0047] The method for constructing the characteristic spectrum of this application involves using appropriate test sample preparation and chromatographic detection conditions to perform high-performance liquid chromatography detection on Yangshen Buxue Granules, thereby constructing a characteristic spectrum of Yangshen Buxue Granules containing multiple characteristic peaks. This spectrum can comprehensively reflect the intrinsic chemical composition of Yangshen Buxue Granules and can be used to objectively, comprehensively, and accurately evaluate the quality of Yangshen Buxue Granules.
[0048] The detection method of this application employs appropriate preparation of the test sample and chromatographic detection conditions to detect the complex multi-source substance system of Yangshen Buxue Granules. After methodological verification, it has the advantages of good specificity, good stability, good repeatability, good intermediate precision, and good robustness. Attached Figure Description
[0049] To more clearly illustrate the technical solutions in the specific embodiments of this application or the prior art, the drawings used in the description of the specific embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of this application. For those skilled in the art, other drawings can be obtained from these drawings without creative effort.
[0050] Figure 1 The chromatograms are of reference solutions, where S1 is the reference solution of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside, S2 is the reference solution of 5-hydroxymethylfurfural, S3 is the mixed reference solution of 4-coumaric acid and ferulic acid, S4 is the reference solution of processed Polygonum multiflorum, S5 is the reference solution of Lycium barbarum, and S6 is the reference solution of Ziziphus jujuba.
[0051] Figure 2 The peak assignment chromatograms are as follows: S1 is the reference solution of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside; S2 is the reference solution of 5-hydroxymethylfurfural; S3 is the mixed reference solution of 4-coumaric acid and ferulic acid; S4 is the reference solution of processed Polygonum multiflorum; S5 is the reference solution of Lycium barbarum; S6 is the reference solution of Ziziphus jujuba; S7 is the test solution of Yangshen Buxue Granules; and S8 is the blank excipient solution of Yangshen Buxue Granules.
[0052] Figure 3 The image shows the chromatograms of 10 batches of kidney-nourishing and blood-tonifying granules used in the example.
[0053] Figure 4 This is a comparative characteristic spectrum of the kidney-nourishing and blood-tonifying granules in the examples. Detailed Implementation
[0054] The present application is further described below with reference to embodiments and examples. It should be understood that these embodiments are for illustrative purposes only and are not intended to limit the scope of the application. Furthermore, it should be understood that after reading the teachings of this application, those skilled in the art can make various alterations or modifications to this application, and these equivalent forms also fall within the protection scope of the appended claims.
[0055] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this application belongs. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the application.
[0056] In this article, "one or more" refers to any one, two or more of the listed items.
[0057] The term "and / or" as used herein includes any one of two or more related listed items, as well as any and all combinations of the related listed items. These arbitrary and all combinations encompass any two related listed items, any more related listed items, or a combination of all related listed items. It should be noted that when at least three items are connected using at least two conjunctions selected from "and / or," it should be understood that, in this application, the technical solution undoubtedly includes solutions connected using "logical AND," and also undoubtedly includes solutions connected using "logical OR." For example, "A and / or B" includes three parallel solutions: A, B, and A+B.
[0058] In this document, terms such as "further," "even further," and "particularly" are used for descriptive purposes to indicate differences in content, but should not be construed as limiting the scope of protection of this invention.
[0059] In this application, the technical features described in an open-ended manner include both closed technical solutions consisting of the listed features and open technical solutions that include the listed features.
[0060] In this application, numerical intervals (i.e., numerical ranges) are involved. Unless otherwise specified, optional numerical distributions within the aforementioned numerical intervals are considered continuous and include the two endpoints (i.e., the minimum and maximum values) of the numerical range, as well as every value between these two endpoints. Unless otherwise specified, when a numerical interval points to integers within that interval, it includes the two endpoint integers of the numerical range, as well as every integer between the two endpoints. Furthermore, when multiple ranges are provided to describe features or characteristics, these ranges may be merged. In other words, unless otherwise specified, the ranges disclosed herein should be understood to include any and all subranges to which they are included.
[0061] Unless otherwise specified, the percentage content involved in this invention refers to mass percentage for solid-liquid mixtures and solid-phase-solid mixtures, and volume percentage for liquid-phase-liquid mixtures.
[0062] Unless otherwise specified, all percentage concentrations mentioned in this invention refer to the final concentration. The final concentration refers to the proportion of the added component in the system after the addition of that component.
[0063] Unless otherwise specified, the temperature parameters in this invention allow for both isothermal processing and processing within a certain temperature range. The isothermal processing allows temperature fluctuations within the precision range controlled by the instrument. Fluctuations are permitted within ranges such as ±0.8°C, ±0.5°C, ±0.4°C, ±0.3°C, ±0.2°C, and ±0.1°C. In this invention, "room temperature" or "normal temperature" refers to the absence of temperature control operations, generally meaning 4°C to 35°C, preferably 20±5°C.
[0064] In recent years, with the rapid development of chromatography and mass spectrometry, the characteristic spectral technology of traditional Chinese medicine has been widely applied and improved. Spectroscopy (including ultraviolet, visible, and infrared spectroscopy), wave spectroscopy (including mass spectrometry and nuclear magnetic resonance spectroscopy), chromatography (including thin-layer chromatography, high-performance liquid chromatography, gas chromatography, etc.), and various coupled-instrument techniques can all be used as research methods for the characteristic spectral analysis of traditional Chinese medicine. These techniques enable comprehensive analysis of raw medicinal materials, processed medicinal materials, and prepared Chinese medicines, providing a reliable basis for quality control.
[0065] Currently, there are few reports on detection methods for Yangshen Buxue Granules, and existing detection methods fail to encompass the entire material group of Yangshen Buxue Granules.
[0066] After extensive investigation of chromatographic conditions and methodologies, the technical personnel of this application discovered that by using appropriate sample preparation and chromatographic detection conditions to detect Yangshen Buxue Granules, the constructed characteristic chromatogram has advantages such as a large number of characteristic peaks, comprehensive coverage, symmetrical peak shapes, and stable baselines. Moreover, this method is simple to operate, has good specificity, stability, and repeatability, high intermediate precision, and good robustness. It can be used to evaluate the uniformity and stability of Yangshen Buxue Granules quality, which is of great significance for improving the overall quality control level of Yangshen Buxue Granules.
[0067] One or more embodiments of this application provide a method for constructing the feature map of kidney-nourishing and blood-tonifying granules, including the following steps:
[0068] The test sample was extracted using an extraction solvent to prepare a test sample solution; the test sample was a kidney-nourishing and blood-tonifying granule; the raw materials of the kidney-nourishing and blood-tonifying granule included pig blood extract, processed Polygonum multiflorum, wolfberry and jujube;
[0069] The characteristic chromatogram of the kidney-nourishing and blood-tonifying granules was obtained by high-performance liquid chromatography detection of the test solution.
[0070] The conditions for high-performance liquid chromatography (HPLC) detection include:
[0071] Mobile phase A is acetonitrile, and mobile phase B is an aqueous solution of phosphoric acid, with a volume percentage of phosphoric acid of 0.08-0.12%; the flow rate is 0.85 mL / min-0.95 mL / min; gradient elution is used.
[0072] The gradient elution procedure includes:
[0073] From 0 to 25 minutes, the volume percentage of mobile phase A was maintained at 3%.
[0074] Between 25 and 40 minutes, the volume percentage of mobile phase A increased from 3% to 11%.
[0075] From 40 min to 85 min, the volume percentage of mobile phase A increased from 11% to 15%;
[0076] Between 85 and 110 minutes, the volume percentage of mobile phase A increased from 15% to 18%.
[0077] Optionally, the volume percentage of phosphoric acid in the aqueous solution of phosphoric acid is 0.08-0.12%, including but not limited to 0.08%, 0.09%, 0.1%, 0.11%, 0.12%, etc.
[0078] Optionally, the flow rate can be 0.85 mL / min to 0.95 mL / min, including but not limited to 0.85 mL / min, 0.87 mL / min, 0.90 mL / min, 0.92 mL / min, 0.95 mL / min, etc.
[0079] In some embodiments, high-performance liquid chromatography is used to detect multiple batches (e.g., 10-30 batches) of test sample solutions to obtain a series of test sample chromatograms. These chromatograms are then imported into a traditional Chinese medicine chromatographic fingerprint similarity evaluation system for processing, characteristic peaks are selected, and characteristic chromatograms of Yangshen Buxue Granules are formulated.
[0080] In some embodiments, the conditions for high-performance liquid chromatography (HPLC) detection further include using an octadecylsilane-bonded silica column as the packing material.
[0081] Furthermore, the chromatographic column has a length of 240mm-260mm, an inner diameter of 4.5mm-4.7mm, and a packing particle size of 4μm-6μm.
[0082] Optionally, the column type may include, but is not limited to, Welch Ultimate LP-C18 (4.6×250mm, 5μm) and Agilent ZORBAX SB-C18 (4.6×250mm, 5μm).
[0083] In some embodiments, the conditions for high-performance liquid chromatography (HPLC) detection also include a column temperature of 25°C-35°C. Further, the column temperature is 28°C-32°C, including but not limited to 28°C, 29°C, 30°C, 31°C, and 32°C.
[0084] In some embodiments, the conditions for high-performance liquid chromatography (HPLC) detection also include an injection volume of 15 μL-25 μL, including but not limited to 15 μL, 16 μL, 17 μL, 18 μL, 19 μL, 20 μL, 21 μL, 2 μL, 23 μL, 24 μL, 25 μL, etc.
[0085] In some embodiments, the conditions for high-performance liquid chromatography detection also include a detection wavelength of 190nm-400nm, including but not limited to 260nm, 265nm, 270nm, 275nm, 280nm, 285nm, 290nm, 295nm, etc.
[0086] In some embodiments, the weight-volume ratio of the kidney-nourishing and blood-tonifying granules to the extraction solvent is (4-6) g: (20-100) mL, including but not limited to 5 g: 20 mL, 5 g: 25 mL, 5 g: 50 mL, 4 g: 100 mL, 5 g: 100 mL, 6 g: 100 mL, etc.
[0087] In some embodiments, the extraction solvent comprises an aqueous solution of an alcohol with a volume concentration of 0%-100%.
[0088] Alternatively, the alcohol includes one or more of methanol and ethanol.
[0089] In some embodiments, the extraction solvent is an aqueous solution of methanol with a volume concentration of 60%-80%.
[0090] In some embodiments, in the step of extracting the kidney-nourishing and blood-tonifying granules using an extraction solvent, the extraction method is one or more of ultrasonic extraction and reflux extraction.
[0091] Furthermore, the extraction time can be 20 min to 60 min, including but not limited to 20 min, 30 min, 40 min, 50 min and 60 min.
[0092] In some embodiments, the step of extracting the test sample using an extraction solvent includes: mixing the test sample and the extraction solvent, and subjecting the resulting mixture to hot reflux extraction;
[0093] Optionally, the conditions for hot reflux extraction include: a heating temperature of 80℃-90℃ and a hot reflux extraction time of 20min-60min.
[0094] Further, the resulting mixture is subjected to hot reflux extraction, filtered, and the filtrate is evaporated to dryness and reconstituted with a solvent. In this embodiment, the solvent used for reconstitution can be selected from the same solvent used for extraction. The volume of the reconstituted solution can be 2-5 mL.
[0095] In some embodiments, the characteristic spectrum of the kidney-nourishing and blood-tonifying granules includes eight peaks, namely peak 1, peak 2, peak 3, peak 4, peak 5, peak 6, peak 7, and peak 8.
[0096] Among them, peak 2 is 5-hydroxymethylfurfural, peak 6 is 4-coumaric acid, peak 7 is ferulic acid, and peak 8 is 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside.
[0097] In some implementations, peak 2 is used as reference peak S1, and the relative retention times of peaks 1 and 3 with peak S1 are 0.62±10% and 1.39±10%, respectively.
[0098] With peak 8 as the reference peak S2, the relative retention times of peaks 4, 5, 6, and 7 with peak S2 are 0.46±10%, 0.47±10%, 0.72±10%, and 0.83±10%, respectively.
[0099] In some implementations, the method for constructing feature maps further includes the following steps:
[0100] A reference solution is prepared by mixing a reference standard with an organic solvent; the reference standard includes one or more of 5-hydroxymethylfurfural, 4-coumaric acid, ferulic acid, and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside.
[0101] The reference solution was subjected to high-performance liquid chromatography (HPLC) to obtain the chromatogram of the reference standard.
[0102] In some embodiments, the mass concentration of each solute in the reference solution—5-hydroxymethylfurfural, 4-coumaric acid, ferulic acid, or 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside—is 30 μg / mL to 100 μg / mL.
[0103] In one specific example, the method for constructing the feature map of kidney-nourishing and blood-tonifying granules includes the following steps:
[0104] (1) Preparation of reference solution:
[0105] Mixed reference solution: Weigh appropriate amounts of 5-hydroxymethylfurfural reference standard and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside reference standard, dissolve them in 70% methanol, dilute to the mark, shake well, filter, and collect the filtrate to obtain the solution.
[0106] (2) Preparation of the test solution:
[0107] Kidney-Nourishing and Blood-Replenishing Granules: Take an appropriate amount of sample, grind it into a fine powder, accurately weigh it, place it in an Erlenmeyer flask, add an appropriate amount of methanol, weigh it, heat under reflux, cool it, shake it well, filter it, evaporate the filtrate to dryness, dissolve the residue in an appropriate amount of water, extract it with n-butanol by shaking several times, each time in an appropriate amount, combine the n-butanol solutions, wash it with an appropriate amount of water, let it stand for a suitable number of minutes, discard the water, evaporate the n-butanol solution to dryness, dissolve the residue in 70% methanol, transfer it to a volumetric flask, dilute it to the mark with 70% methanol, shake it well, filter it, and take the filtrate to obtain the product.
[0108] (3) Chromatographic conditions
[0109] High-performance liquid chromatography (HPLC) was used for detection. The column was packed with octadecylsilane-bonded silica gel, mobile phase A was acetonitrile, and mobile phase B was an aqueous phosphoric acid solution. Gradient elution was employed.
[0110] The gradient elution procedure includes:
[0111] From 0 to 25 minutes, the volume percentage of mobile phase A was maintained at 3%.
[0112] Between 25 and 40 minutes, the volume percentage of mobile phase A increased from 3% to 11%.
[0113] From 40 min to 85 min, the volume percentage of mobile phase A increased from 11% to 15%;
[0114] Between 85 and 110 minutes, the volume percentage of mobile phase A increased from 15% to 18%.
[0115] (4) Characteristic spectrum determination
[0116] Inject the mixed reference solution from step (1) and the test solution from step (2) into the high performance liquid chromatograph, and detect them according to the chromatographic conditions in step (3) to obtain the chromatograms of the corresponding mixed reference standard and test sample, and calculate the relative retention time of each characteristic peak.
[0117] (5) Establishment of characteristic maps
[0118] The chromatograms of the test samples were imported into the chromatographic fingerprint similarity evaluation system for traditional Chinese medicine for processing. The main chromatographic peaks that were present in the chromatograms of different batches of test samples were selected as characteristic peaks to construct a control characteristic chromatogram of Yangshen Buxue Granules.
[0119] One or more embodiments of this application also provide a method for detecting kidney-nourishing and blood-tonifying granules, including the following steps:
[0120] The sample to be tested was extracted using an extraction solvent to prepare a solution; the sample to be tested was a kidney-nourishing and blood-tonifying granule; the raw materials of the kidney-nourishing and blood-tonifying granule included pig blood extract, processed Polygonum multiflorum, wolfberry, and jujube;
[0121] The test solution was subjected to high performance liquid chromatography to obtain a chromatogram of the test sample;
[0122] A reference solution is prepared by mixing a reference compound with an organic solvent; the reference compound includes 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside.
[0123] The reference solution was subjected to high performance liquid chromatography to obtain a reference chromatogram, and the chromatogram of the test sample and the reference chromatogram were compared.
[0124] The conditions for the high-performance liquid chromatography detection include:
[0125] Mobile phase A is acetonitrile, and mobile phase B is an aqueous solution of phosphoric acid, wherein the volume percentage of phosphoric acid in the aqueous solution is 0.08-0.12%; the flow rate is 0.85 mL / min-0.95 mL / min; gradient elution is used;
[0126] The gradient elution procedure includes:
[0127] From 0 to 25 minutes, the volume percentage of the mobile phase A is maintained at 3%.
[0128] Between 25 and 40 minutes, the volume percentage of mobile phase A increased from 3% to 11%.
[0129] From 40 min to 85 min, the volume percentage of the mobile phase A increased from 11% to 15%.
[0130] Between 85 and 110 minutes, the volume percentage of the mobile phase A increased from 15% to 18%.
[0131] In the above detection method, in an exemplary embodiment, the chromatogram of the test sample contains eight characteristic peaks. Peaks 2 and 8 correspond to the retention times of the reference peaks 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside, respectively. Further, using the peak corresponding to the 5-hydroxymethylfurfural reference peak as S1, the relative retention times of peaks 1 and 3 with S1 are calculated. These relative retention times should be within ±10% of a specified value, which is 0.62 (peak 1) and 1.39 (peak 3). Using the peak corresponding to the 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside reference peak as S2, the relative retention times of peaks 4, 5, 6, and 7 with S2 are calculated. These relative retention times should be within ±10% of a specified value, which is 0.46 (peak 4), 0.47 (peak 5), 0.72 (peak 6), and 0.83 (peak 7).
[0132] The present invention will be further described in detail below with reference to specific embodiments. Experimental parameters not specified in the following embodiments should first be referred to the guidelines given in this application, and may also be referred to experimental manuals or other experimental methods known in the art, or the experimental conditions recommended by the manufacturer. It is understood that the instruments and materials used in the following embodiments are relatively specific, and may not be limited to these in other embodiments.
[0133] The instruments and materials used in this embodiment are as follows:
[0134] Instruments: LC-2050 high performance liquid chromatograph (Shimadzu Malaysia factory); Agilent 1260 II high performance liquid chromatograph (Agilent Technologies China); UV detector (DAD); SQP electronic analytical balance (Sartorius Scientific Instruments (Beijing) Co., Ltd.); JA5003 electronic analytical balance (Shanghai Sunny Hengping Scientific Instruments Co., Ltd.); KQ5200DE ultrasonic cleaner (Kunshan Ultrasonic Instruments Co., Ltd.)
[0135] Reference standards: 5-hydroxymethylfurfural (batch number 111626-202417) and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (110848-202317) were purchased from the National Institutes for Food and Drug Control.
[0136] Reagents: Acetonitrile (chromatographic grade); methanol (analytical grade); phosphoric acid (analytical grade); ultrapure water.
[0137] Test sample: Kidney-nourishing and blood-tonifying granules (batch numbers: 01250902S, 01251001S, 01251002S, 01251101S, 01251102S, 01251201S, 01251202S, 01260101, 01260102, 01260103; specification: 5g / bag; source: Guangdong Red Coral Pharmaceutical Co., Ltd.).
[0138] The specific preparation steps for kidney-nourishing and blood-tonifying granules are as follows:
[0139] The pig blood extract of this application was prepared according to the preparation method of pig blood extract recorded under the Yiqi Weixue Granules section of the 2025 edition of the Pharmacopoeia of the People's Republic of China, and the content determination results meet the relevant provisions of the Pharmacopoeia.
[0140] Take 200g of processed Polygonum multiflorum, 200g of wolfberry, and 200g of jujube, add water and decoct twice, 2 hours each time. Filter the decoction twice and concentrate it into an extract. Add 260g of pig blood extract, 80g of dextrin, 15g of povidone K30, 3.14g of vanillin, 2g of steviol glycosides and an appropriate amount of mannitol, make into granules, dry, add 2.33g of sweet orange oil flavoring, mix well, and make 1000g to obtain kidney-nourishing and blood-tonifying granules.
[0141] Example 1
[0142] This embodiment describes the screening of detection conditions and identification of chromatographic peaks for Yangshen Buxue Granules. The specific steps are as follows:
[0143] Step 1: Preparation of reference solutions: Accurately weigh appropriate amounts of 5-hydroxymethylfurfural, 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside, 4-coumaric acid, and ferulic acid reference standards, and add 70% methanol to prepare reference solutions; each 1 mL of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside reference solution contains approximately 0.1 mg of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside, each 1 mL of 5-hydroxymethylfurfural reference solution contains approximately 30 μg of 5-hydroxymethylfurfural, each 1 mL of the mixed 4-coumaric acid and ferulic acid reference solution contains approximately 50 μg of 4-coumaric acid and approximately 80 μg of ferulic acid;
[0144] Step 2: Preparation of reference herb solutions: Take appropriate amounts of Polygonum multiflorum, Lycium barbarum, and jujube as reference herbs, grind them into fine powder, accurately weigh about 5g of the powder, place it in a stoppered conical flask, add 50ml of methanol, heat under reflux for 30 minutes, filter, evaporate the filtrate to dryness, dissolve the residue in 20ml of water, extract twice with n-butanol (20ml each time), combine the n-butanol extracts, wash with 5ml of water, let stand for 15 minutes, discard the water, evaporate the n-butanol extract to dryness, dissolve the residue in 70% methanol, transfer to a 5ml volumetric flask, add 70% methanol to the mark, shake well, filter, and collect the filtrate to obtain the corresponding reference herb solutions.
[0145] Step 3: Preparation of the test solution: Take an appropriate amount of kidney-nourishing and blood-tonifying granules, grind them into a fine powder, accurately weigh about 5g of the powder, place it in a stoppered conical flask, add 50ml of methanol, heat under reflux for 30 minutes, filter, evaporate the filtrate to dryness, dissolve the residue in 20ml of water, extract twice with n-butanol, 20ml each time, combine the n-butanol extracts, wash with 5ml of water, let stand for 15 minutes, discard the water, evaporate the n-butanol extract to dryness, dissolve the residue in 70% methanol, transfer to a 5ml volumetric flask, add 70% methanol to the mark, shake well, filter, and take the filtrate to obtain the test solution.
[0146] Step 4, Chromatographic conditions: A Welch Ultimate LP-C18 column (4.6 × 250 mm, 5 μm) was used. Acetonitrile was used as mobile phase A, and 0.1% phosphoric acid solution was used as mobile phase B. Gradient elution was performed. The detection wavelength was 290 nm, the column temperature was 30 °C, and the flow rate was 0.9 mL / min. The gradient elution program was as follows: From 0 to 4 min, mobile phase A was maintained at 3%, and mobile phase B was maintained at 97%; from 25 to 40 min, mobile phase A increased from 3% to 11%, and mobile phase B decreased from 97% to 89%; from 40 to 85 min, mobile phase A increased from 11% to 15%, and mobile phase B decreased from 89% to 85%; from 85 to 110 min, mobile phase A increased from 15% to 18%, and mobile phase B decreased from 85% to 82%.
[0147] Step 5: Screening of detection conditions:
[0148] 1. Screening of test sample solution preparation conditions
[0149] In this application, the mass-volume ratio of the sample to the extraction solvent in the preparation step of the test solution was investigated, including but not limited to (4g~6g): (20mL~100mL), the extraction solvent was investigated, including but not limited to methanol and methanol-water solutions with different volume ratios, the extraction method was investigated (reflux, sonication), and the extraction time was investigated (20min~60min).
[0150] 1.1 Examination of Extraction Methods
[0151] Table 1. Suitability parameters of test solution systems for different extraction methods
[0152]
[0153] Based on the above findings, peaks 1, 6 (4-coumaric acid) and 8 (stilbene glycoside peak, abbreviation for 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside) during ultrasonic extraction are significantly smaller than those during reflux extraction, while the changes in other characteristic peaks are relatively small. Therefore, reflux extraction was chosen as the extraction method for preparing the test sample solution.
[0154] 1.2 Investigation of Extraction Solvents
[0155] Table 2. Suitability parameters of test sample solution systems with different extraction solvents
[0156]
[0157]
[0158] Based on the above test results, it can be seen that, except for the 5-hydroxymethylfurfural peak, the peak areas of the other known characteristic peaks all increase proportionally with the increase of methanol ratio. The peak heights of the other unknown characteristic peaks are relatively good. However, in the preparation of the 70% methanol sample, after reflux extraction and cooling, the flowability of the sample solution is very poor, and the sample cannot be filtered. Therefore, 70% methanol is not considered as the extraction solvent, and methanol is selected as the extraction solvent for the preparation of the sample solution.
[0159] 1.3 Investigation of Solvent Addition Amount
[0160] Table 3 Suitability parameters of test sample solution systems with different extraction solvents
[0161]
[0162]
[0163] Based on the above test results, it can be seen that the total peak area increases with the increase of the amount of solvent added. When the amount of solvent added is 50 ml, the peak area of each characteristic peak responds well. Therefore, the method of preparing the test solution is to add 50 ml of solvent.
[0164] 1.4 Sample Quantity Examination
[0165] Table 4 Suitability parameters of test sample solution systems with different extraction solvents
[0166]
[0167] Based on the above test results, it can be seen that as the sample amount increases, the peak area of each characteristic peak increases accordingly. The sample amount is proportional to the total peak area, indicating that the method can completely extract the sample. Therefore, a sample amount of 5.0g was selected as the method for preparing the test solution.
[0168] 1.5 Examination of extraction time
[0169] Table 5. Suitability parameters of test sample solution systems with different extraction solvents
[0170]
[0171]
[0172] According to the above test results, the peak shapes of each characteristic peak are good under different extraction times. However, as the extraction time increases, the peak area of the peaks at 45 to 60 minutes decreases instead of increasing, indicating that the extraction effect is worse when the extraction time is too long. Based on the calculated total peak area, the peak response is best when the extraction time is 30 minutes. Therefore, the extraction time of 30 minutes is selected as the preparation method for the test solution.
[0173] Based on the above research results, the preferred method for preparing the kidney-nourishing and blood-tonifying granules is to heat and reflux with methanol for 30 minutes, and the preferred mass-volume ratio of the sample weight to the extraction solvent is 5g:50mL.
[0174] 2. Screening of high performance liquid chromatography conditions
[0175] 2.1 Elution gradient screening and detection wavelength selection
[0176] Based on the properties of the components contained in the prescription herbs, acetonitrile-0.1% phosphoric acid was initially selected as the mobile phase. A diode array detector was used for detection. When investigating the elution gradient of the mobile phase, a full wavelength scan (190nm-400nm) was initiated. The following chromatographic conditions were explored:
[0177] Chromatographic conditions 1: Gradient elution program: 0-25 min, acetonitrile volume percentage maintained at 3%; 25 min-45 min, acetonitrile volume percentage 3%→10%; 45 min-80 min, acetonitrile volume percentage 10%→15%; 80 min-110 min, acetonitrile volume percentage 15%→17%; column temperature set at 30℃; flow rate 0.8 ml / min.
[0178] Chromatographic conditions 2: Gradient elution program: 0-25 min, acetonitrile volume percentage maintained at 3%; 25 min-40 min, acetonitrile volume percentage 3%→11%; 40 min-85 min, acetonitrile volume percentage 11%→15%; 85 min-110 min, acetonitrile volume percentage 15%→18%; column temperature set at 30℃; flow rate 0.9 ml / min.
[0179] Chromatographic conditions 3: The gradient elution program was as follows: 0-25 min, acetonitrile volume percentage maintained at 3%; 25-45 min, acetonitrile volume percentage 3%→10%; 45-80 min, acetonitrile volume percentage 10%→15%; 80-110 min, acetonitrile volume percentage 15%→17%; column temperature set at 30℃; flow rate 1.0 ml / min. The results are shown in Table 6.
[0180] Table 6. Suitability parameters of test sample solution systems with different extraction solvents
[0181]
[0182] After adjustment and screening, the provisional chromatographic conditions were obtained. The detection wavelength was 290 nm, at which the chromatographic peak response was good and the baseline was flat. The gradient elution program was as follows: 0-25 min, acetonitrile volume percentage maintained at 3%; 25 min-40 min, acetonitrile volume percentage 3%→11%; 40 min-85 min, acetonitrile volume percentage 11%→15%; 85 min-110 min, acetonitrile volume percentage 15%→18%; column temperature was 30℃; flow rate was 0.9 ml / min.
[0183] 2.2 Flow rate, column temperature, column selection and screening
[0184] 2.2.1 Flow velocity investigation
[0185] Table 7 Suitability parameters of test sample solution systems at different flow rates
[0186]
[0187] 2.2.2 Column Temperature Investigation
[0188] Table 8 Suitability parameters of test sample solution systems at different column temperatures
[0189]
[0190]
[0191] 2.2.3 Column Investigation
[0192] Table 9 Suitability parameters for test solution systems of different chromatographic columns
[0193]
[0194] This application compared flow rates of 0.85 mL / min, 0.9 mL / min, and 0.95 mL / min, with minimal differences; 0.9 mL / min was the optimal flow rate. Column temperatures were investigated from 28℃ to 32℃, with minimal differences; 30℃ was the optimal temperature. Columns from different manufacturers and of different models using octadecylsilane-bonded silica gel as packing material were investigated, and the Welch Ultimate LP-C18 was ultimately selected.
[0195] Step 6: Characteristic Peak Selection and Identification
[0196] Based on a review of relevant literature and regulatory requirements, eight characteristic peaks were selected. Peak 2 was designated as reference peak S1, and peak 8 as reference peak S2. Detailed test results for the test sample, relevant reference standards, and reference medicinal materials can be found in [link to relevant documentation]. Figure 1 .
[0197] Eight characteristic peaks in the chromatogram of the test sample were assigned and identified. Four characteristic peaks were identified by the reference standard, corresponding to four different components: peak 2 (reference peak S1) is 5-hydroxymethylfurfural, peak 6 is 4-coumaric acid, peak 7 is ferulic acid, and peak 8 (reference peak S2) is 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside. Peak 1, which was not identified by the reference standard, is a common peak of jujube and wolfberry; peaks 3 and 4 are specific peaks of wolfberry; and peak 5 is a specific peak of processed Polygonum multiflorum. See the assigned chromatogram for details. Figure 2 The identification results are shown in Table 10 below.
[0198] Table 10 Characteristic Peak Identification Results
[0199]
[0200] Based on the above analysis results, the detection standard is specified as follows: with peak 2 as reference peak S1, the relative retention times of peaks 1 and 3 with peak S1 are 0.62±10% and 1.39±10%, respectively; with peak 8 as reference peak S2, the relative retention times of peaks 4, 5, 6, and 7 with peak S2 are 0.46±10%, 0.47±10%, 0.72±10%, and 0.83±10%, respectively.
[0201] Example 2
[0202] In this embodiment, the characteristic chromatogram of the kidney-nourishing and blood-tonifying granules was prepared using the detection conditions screened in Example 1, and the methodology of the detection method was investigated. The specific steps are as follows:
[0203] Step 1: Preparation of reference solution: Accurately weigh appropriate amounts of 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside reference standards, add 70% methanol to prepare a mixed solution containing approximately 30 μg of 5-hydroxymethylfurfural and approximately 0.1 mg of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside per mL. Filter the solution and use the filtrate as the reference solution.
[0204] Step 2: Preparation of the test solution: Take an appropriate amount of sample, grind it into a fine powder, accurately weigh about 5g of the powder, place it in a stoppered conical flask, add 50ml of methanol, heat under reflux for 30 minutes, filter, evaporate the filtrate to dryness, dissolve the residue in 20ml of water, extract twice with n-butanol (20ml each time), combine the n-butanol extracts, wash with 5ml of water, let stand for 15 minutes, discard the aqueous solution, evaporate the n-butanol extract to dryness, dissolve the residue in 70% methanol, transfer to a 5ml volumetric flask, add 70% methanol to the mark, shake well, filter, and collect the filtrate to obtain the test solution.
[0205] Step 3: Prepare blank excipient solution: Weigh 2.15g mannitol, 0.35g dextrin, 0.07g povidone K30, 0.01g vanillin, 0.01g sweet orange oil, and 0.01g steviol glycosides, place them in a stoppered conical flask, add 50ml methanol, heat under reflux for 30 minutes, filter, evaporate the filtrate to dryness, dissolve the residue in 20ml water, extract twice with n-butanol (20ml each time), combine the n-butanol extracts, wash with 5ml water, let stand for 15 minutes, discard the aqueous solution, evaporate the n-butanol extract to dryness, dissolve the residue in 70% methanol, transfer to a 5ml volumetric flask, add 70% methanol to the mark, shake well, filter, and collect the filtrate as the excipient blank solution.
[0206] Step 4, Liquid Chromatography Conditions: A Welch Ultimate LP-C18 column (4.6 × 250 mm, 5 μm) was used. Acetonitrile was used as mobile phase A, and 0.1% phosphoric acid solution was used as mobile phase B. Gradient elution was performed. The detection wavelength was 290 nm, the column temperature was 30 °C, and the flow rate was 0.9 mL / min. The gradient elution program was as follows: From 0 to 4 min, mobile phase A was maintained at 3%, and mobile phase B was maintained at 97%; from 25 to 40 min, mobile phase A increased from 3% to 11%, and mobile phase B decreased from 97% to 89%; from 40 to 85 min, mobile phase A increased from 11% to 15%, and mobile phase B decreased from 89% to 85%; from 85 to 110 min, mobile phase A increased from 15% to 18%, and mobile phase B decreased from 85% to 82%.
[0207] Step 5, Determination: Accurately pipette 20 μL of the reference solution and 20 μL of each of the 10 batches of Yangshen Buxue Granules prepared according to the method in Step 2, and inject them into the high-performance liquid chromatograph for detection. Record the chromatograms. Figure 3 As shown. The chromatograms of 10 batches of Yangshen Buxue Granules test solutions were imported into the Traditional Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System; eight major chromatographic peaks present in the chromatograms of each batch of Yangshen Buxue Granules were selected as characteristic peaks; a control characteristic chromatogram of Yangshen Buxue Granules was generated using the average value calculation method, as shown in the figure. Figure 4In the characteristic chromatograms of 10 batches of kidney-nourishing and blood-tonifying granules, characteristic peak 2 was 5-hydroxymethylfurfural with an average retention time of 18.223 min; characteristic peak 6 was 4-coumaric acid with an average retention time of 67.727 min; characteristic peak 7 was ferulic acid with an average retention time of 78.102 min; and characteristic peak 8 was 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside with an average retention time of 93.976 min. Using the peak corresponding to the 5-hydroxymethylfurfural reference peak as peak S1 (characteristic peak 2), peaks 1 and 2 were calculated respectively. The relative retention times of peaks 3 and S1 were calculated. The average relative retention times for 10 batches were 0.62 (characteristic peak 1) and 1.39 (characteristic peak 3). Taking the peak corresponding to the reference peak of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside as peak S2 (characteristic peak 8), the relative retention times of peaks 4, 5, 6, and 7 with peak S2 were calculated. The average relative retention times for 10 batches were 0.46 (characteristic peak 4), 0.47 (characteristic peak 5), 0.72 (characteristic peak 6), and 0.83 (characteristic peak 7).
[0208] Table 11 Summary of Characteristic Map Data Results for Batch Nourishing Kidney and Blood-Nourishing Granules
[0209]
[0210] In Table 11, relative retention time = characteristic peak retention time / reference peak retention time.
[0211] The methodological study of the characteristic spectrum detection method for kidney-nourishing and blood-tonifying granules is as follows:
[0212] (1) Specificity research
[0213] Prepare a test solution using the kidney-nourishing and blood-tonifying granules (batch number: 01260103) according to the method in step 2. Prepare an excipient blank solution using the method in step 3. Accurately pipette 20 μl each of the excipient blank solution, reference solution, and test solution, and analyze them according to the detection method in step 4. The test sample chromatogram should show 8 characteristic peaks. Peaks 2 and 8 should correspond to the retention times of the reference peaks 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside. The peak corresponding to the 5-hydroxymethylfurfural reference peak is peak S1 (characteristic peak 2). Calculate the relative retention times of peaks 1 and 3 with peak S1. The relative retention times should be within ±10% and the RSD value within ±3%. The specified values were 0.62 (characteristic peak 1) and 1.39 (characteristic peak 3). The peak corresponding to the reference peak of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside was peak S2 (characteristic peak 8). The relative retention times of peaks 4, 5, 6, and 7 with peak S2 were calculated, and their relative retention times were within ±10% and RSD values were within ±3%. The specified values were 0.46 (characteristic peak 4), 0.47 (characteristic peak 5), 0.72 (characteristic peak 6), and 0.83 (characteristic peak 7). The retention times / relative retention times of each characteristic peak are summarized in Table 12 below. The results show that there was no interference from the excipient blank, and the method has good specificity.
[0214] Table 12 Results of the specificity study of Yangshen Buxue Granules
[0215]
[0216] (2) Reproducibility studies
[0217] Six parallel samples of Yangshen Buxue Granules (batch number: 01260103) were accurately weighed and prepared into six test solutions according to the method in step 2. The samples were analyzed according to the detection method in step 4. The characteristic chromatogram of the test samples should show eight characteristic peaks. Among them, characteristic peaks 2 and 8 should correspond to the retention times of the reference peaks of 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside. The peak corresponding to the 5-hydroxymethylfurfural reference peak is peak S1 (characteristic peak 2). The relative retention times of peaks 1 and 3 with peak S1 were calculated respectively. The relative retention times should be within ±10% and the RSD value should be within ±3%. The specified values are: 0.62 (characteristic peak 1) and 1.39 (characteristic peak 3). The peak corresponding to the reference peak of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside is peak S2 (characteristic peak 8). The relative retention times of peaks 4, 5, 6, and 7 with peak S2 were calculated, and their relative retention times were within ±10% and RSD values were within ±3%. The specified values are: 0.46 (characteristic peak 4), 0.47 (characteristic peak 5), 0.72 (characteristic peak 6), and 0.83 (characteristic peak 7). The retention times / relative retention times of each characteristic peak are summarized in Table 13 below, and the results show that the method has good repeatability.
[0218] Table 13 Results of the repeatability study of kidney-nourishing and blood-tonifying granules
[0219]
[0220] (3) Stability study
[0221] The reference solution was prepared according to the reference solution method in step 1, and analyzed according to the detection method in step 4. The sample was injected and analyzed at different time points of 0, 14, 22, 30, 44 and 64 hours, and the chromatograms were recorded. The chromatograms showed two characteristic peaks, namely the 5-hydroxymethylfurfural peak and the 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside peak. The RSD% values of their retention time and peak area were calculated and summarized in Table 14 below.
[0222] Prepare the test solution using the kidney-nourishing and blood-tonifying granules according to the method in step 2. Analyze according to the detection method in step 4, using injection analysis at different time points of 0, 8, 16, 30, 50, and 70 hours. The characteristic chromatogram of the test sample should show 8 characteristic peaks. Among them, characteristic peaks 2 and 8 should correspond to the retention times of the reference peaks of 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside. The peak corresponding to the 5-hydroxymethylfurfural reference peak is peak S1 (characteristic peak 2). Calculate the relative retention times of peaks 1 and 3 with peak S1. The relative retention times should be within ±10% and the RSD value should be within ±3%. The specified values are: 0.62 (characteristic peak 1) and 1.39 (characteristic peak 3). The peak corresponding to the reference peak of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside is peak S2 (characteristic peak 8). The relative retention times of peaks 4, 5, 6, and 7 with peak S2 were calculated, and their relative retention times were within ±10% and RSD values were within ±3%. The specified values are: 0.46 (characteristic peak 4), 0.47 (characteristic peak 5), 0.72 (characteristic peak 6), and 0.83 (characteristic peak 7). The retention times / relative retention times of each characteristic peak are summarized in Table 14 below. The results show that the chromatographic peaks of the reference solution and the test solution of Yangshen Buxue Granules showed almost no change within 64 hours, indicating that the method has good stability.
[0223] Table 14 Results of the stability study of Yangshen Buxue Granules
[0224]
[0225] (4) Intermediate precision study
[0226] Six samples of Yangshen Buxue Granules (batch number: 01260103) were precisely weighed in parallel by different personnel using different instruments. Six test solutions were prepared according to the method in step 2. Analysis was performed according to the detection method in step 4. The characteristic chromatogram of the test samples should show eight characteristic peaks. Among them, characteristic peaks 2 and 8 should correspond to the retention times of the reference peaks of 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside. The peak corresponding to the 5-hydroxymethylfurfural reference peak is peak S1 (characteristic peak 2). The relative retention times of peaks 1 and 3 with peak S1 were calculated, and their relative retention times were within ±10% and their RSD values were within ±3%. The specified values are: 0.62 (characteristic peak 1) and 1.39 (characteristic peak 3). The peak corresponding to the reference peak of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside is peak S2 (characteristic peak 8). The relative retention times of peaks 4, 5, 6, and 7 with peak S2 were calculated, and their relative retention times were within ±10% and RSD values were within ±3%. The specified values are: 0.46 (characteristic peak 4), 0.47 (characteristic peak 5), 0.72 (characteristic peak 6), and 0.83 (characteristic peak 7). The retention times / relative retention times of each characteristic peak are summarized in Table 15 below, indicating that the method has good intermediate precision.
[0227] Table 15 Results of intermediate precision study of kidney-nourishing and blood-tonifying granules
[0228]
[0229] (5) Durability study
[0230] 5.1 Durability of Different Chromatographic Columns
[0231] Prepare a test solution using the kidney-nourishing and blood-tonifying granules according to the method described in step 2. Analyze the solution according to the detection method described in step 4. Examine different chromatographic columns (Column 1: Agilent ZORBAX SB-C18 4.6×250mm 5μm, SN: USCL088640; Column 2: Welch Ultimate LP-C18 4.6×250mm 5μm, SN: 60210102006; Column 3: Welch Ultimate LP-C18 4.6×250mm 5μm, SN: 60180500866). The test solution should show 8 characteristic peaks in its chromatogram. Among them, characteristic peaks 2 and 8 should correspond to the retention times of the reference peaks of 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside. The peak corresponding to the 5-hydroxymethylfurfural reference peak is peak S1 (characteristic peak 2). The relative retention times of peaks 1 and 3 with peak S1 were calculated, with the relative retention times within ±10% and RSD values within ±3%. The specified values are: 0.62 (characteristic peak 1) and 1.39 (characteristic peak 3). The peak corresponding to the 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside reference peak is peak S2 (characteristic peak 8). The relative retention times of peaks 4, 5, 6, and 7 with peak S2 were calculated, with the relative retention times within ±10% and RSD values within ±3%. The specified values are: 0.46 (characteristic peak 4), 0.47 (characteristic peak 5), 0.72 (characteristic peak 6), and 0.83 (characteristic peak 7). The calculated retention times / relative retention times of each characteristic peak are summarized in Table 16 below. The results show that this method has good robustness with different chromatographic columns.
[0232] Table 16 Results of the durability study of different chromatographic columns for Yangshen Buxue Granules
[0233]
[0234] 5.2 Durability at different flow rates
[0235] Prepare the test solution using the kidney-nourishing and blood-tonifying granules according to the method described in step 2. Analyze the solution according to the detection method described in step 4, examining different flow rates (0.85 ml / min, 0.9 ml / min, 0.95 ml / min). The characteristic chromatogram of the test solution should show 8 characteristic peaks. Among them, characteristic peaks 2 and 8 should correspond to the retention times of the reference peaks of 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside. The peak corresponding to the 5-hydroxymethylfurfural reference peak is peak S1 (characteristic peak 2). Calculate the relative retention times of peaks 1 and 3 with peak S1, respectively. The relative retention times should be within ±10% and the RSD value should be within ±3%. The specified values are: 0.62 (characteristic peak 1) and 1.39 (characteristic peak 3). The peak corresponding to the reference peak of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside is peak S2 (characteristic peak 8). The relative retention times of peaks 4, 5, 6, and 7 with peak S2 were calculated, and their relative retention times were within ±10% and RSD values were within ±3%. The specified values are: 0.46 (characteristic peak 4), 0.47 (characteristic peak 5), 0.72 (characteristic peak 6), and 0.83 (characteristic peak 7). The retention times / relative retention times of each characteristic peak are summarized in Table 17 below. The results show that this method has good robustness at different flow rates.
[0236] Table 17 Results of the study on the durability of kidney-nourishing and blood-tonifying granules at different flow rates
[0237]
[0238] 5.3 Durability at different column temperatures
[0239] Prepare the test solution using the kidney-nourishing and blood-tonifying granules according to the method in step 2. Analyze the solution according to the detection method in step 4, examining different column temperatures (28℃, 30℃, 32℃). The characteristic chromatogram of the test solution should show 8 characteristic peaks, among which characteristic peaks 2 and 8 should correspond to the retention times of the reference peaks of 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside. The peak corresponding to the 5-hydroxymethylfurfural reference peak is peak S1 (characteristic peak 2). Calculate the relative retention times of peaks 1 and 3 with peak S1, respectively. The relative retention times should be within ±10% and the RSD value within ±3%. The specified values are: 0.62 (characteristic peak 1) and 1.39 (characteristic peak 3). The peak corresponding to the reference peak of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside is peak S2 (characteristic peak 8). The relative retention times of peaks 4, 5, 6, and 7 with peak S2 were calculated, and their relative retention times were within ±10% and RSD values were within ±3%. The specified values are: 0.46 (characteristic peak 4), 0.47 (characteristic peak 5), 0.72 (characteristic peak 6), and 0.83 (characteristic peak 7). The retention times / relative retention times of each characteristic peak are summarized in Table 18 below. The results show that this method has good robustness at different column temperatures.
[0240] Table 18 Results of the study on the durability of kidney-nourishing and blood-tonifying granules at different column temperatures
[0241]
[0242] The control characteristic spectrum obtained in Example 1 showed all eight characteristic peaks, with the relative retention time of each peak within ±10% of the specified value, and the RSD% ranging from 0.00% to 2.15%, which is less than the specified ±3%. These experimental results demonstrate that the characteristic spectrum detection method for Yangshen Buxue Granules provided in this application has good specificity, stability, repeatability, intermediate precision, and robustness. It can comprehensively and objectively evaluate the quality of Yangshen Buxue Granules, which is of great significance for ensuring clinical efficacy.
[0243] The technical features of the above-described embodiments and examples can be combined in any suitable manner. For the sake of brevity, not all possible combinations of the technical features in the above-described embodiments and examples are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0244] The embodiments described above merely illustrate several implementation methods of this application and should not be construed as limiting the scope of the patent application. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of this application, and these all fall within the protection scope of this application. Furthermore, it should be understood that after reading the above teachings, those skilled in the art can make various alterations or modifications to this application, and the equivalent forms obtained also fall within the protection scope of this application. It should also be understood that technical solutions obtained by those skilled in the art based on the technical solutions provided in this application through logical analysis, reasoning, or limited experimentation are all within the protection scope of the appended claims. Therefore, the protection scope of this patent application should be determined by the appended claims, and the specification can be used to interpret the content of the claims.
Claims
1. A method for constructing the characteristic spectrum of kidney-nourishing and blood-tonifying granules, characterized in that, Includes the following steps: The test sample was extracted using an extraction solvent to prepare a test sample solution; the test sample was a kidney-nourishing and blood-tonifying granule; the raw materials of the kidney-nourishing and blood-tonifying granule included pig blood extract, processed Polygonum multiflorum, wolfberry, and jujube; The test solution was subjected to high performance liquid chromatography to obtain the characteristic chromatogram of the kidney-nourishing and blood-tonifying granules; The conditions for the high-performance liquid chromatography detection include: Mobile phase A is acetonitrile, and mobile phase B is an aqueous solution of phosphoric acid, wherein the volume percentage of phosphoric acid in the aqueous solution is 0.08-0.12%; the flow rate is 0.85 mL / min-0.95 mL / min; gradient elution is used; The gradient elution procedure includes: From 0 to 25 minutes, the volume percentage of the mobile phase A is maintained at 3%. Between 25 and 40 minutes, the volume percentage of mobile phase A increased from 3% to 11%. From 40 min to 85 min, the volume percentage of the mobile phase A increased from 11% to 15%. Between 85 and 110 minutes, the volume percentage of the mobile phase A increased from 15% to 18%.
2. The method for constructing a feature map according to claim 1, characterized in that, The conditions for high-performance liquid chromatography detection also include at least one of the following (1)-(4): (1) The chromatographic column was packed with octadecylsilane-bonded silica gel; (2) Column temperature is 25℃-35℃; (3) The injection volume is 15 μL-25 μL; (4) The detection wavelength is 190nm-400nm.
3. The method for constructing a feature map according to claim 2, characterized in that, The chromatographic column has a length of 240mm-260mm, an inner diameter of 4.5mm-4.7mm, and a packing particle size of 4μm-6μm.
4. The method for constructing a feature map according to any one of claims 1-3, characterized in that, The weight-to-volume ratio of the kidney-nourishing and blood-tonifying granules to the extraction solvent is 2-3g:10-50mL.
5. The method for constructing a feature map according to any one of claims 1-3, characterized in that, The extraction solvent includes an aqueous solution of alcohol with a volume concentration of 0%-100%; Optionally, the alcohol includes one or more of methanol and ethanol.
6. The method for constructing a feature map according to any one of claims 1-3, characterized in that, The steps of extracting the test sample using an extraction solvent include: mixing the test sample and the extraction solvent, and subjecting the resulting mixture to hot reflux extraction; Optionally, the conditions for hot reflux extraction include: a heating temperature of 80℃-100℃ and a hot reflux extraction time of 20min-60min.
7. The method for constructing a feature map according to any one of claims 1-3, characterized in that, The characteristic spectrum of the kidney-nourishing and blood-tonifying granules includes 8 characteristic peaks, namely peak 1, peak 2, peak 3, peak 4, peak 5, peak 6, peak 7, and peak 8; Among them, peak 2 is 5-hydroxymethylfurfural, peak 6 is 4-coumaric acid, peak 7 is ferulic acid, and peak 8 is 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside.
8. The method for constructing a feature map according to claim 7, characterized in that: With peak 2 as the reference peak S1, the relative retention times of peaks 1 and 3 with peak S1 were 0.62±10% and 1.39±10%, respectively. With peak 8 as the reference peak S2, the relative retention times of peaks 4, 5, 6, and 7 with peak S2 are 0.46±10%, 0.47±10%, 0.72±10%, and 0.83±10%, respectively.
9. The method for constructing a feature map according to any one of claims 1-3 and 8, characterized in that, It also includes the following steps: A reference solution is prepared by mixing a reference standard with an organic solvent; the reference standard includes one or more of 5-hydroxymethylfurfural, 4-coumaric acid, ferulic acid, and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside. The reference solution was subjected to high-performance liquid chromatography (HPLC) to obtain a chromatogram of the reference standard.
10. A method for detecting kidney-nourishing and blood-tonifying granules, characterized in that, Includes the following steps: The sample to be tested was extracted using an extraction solvent to prepare a solution; the sample to be tested was a kidney-nourishing and blood-tonifying granule; the raw materials of the kidney-nourishing and blood-tonifying granule included pig blood extract, processed Polygonum multiflorum, wolfberry, and jujube; The test solution was subjected to high performance liquid chromatography to obtain a chromatogram of the test sample; A reference solution is prepared by mixing a reference compound with an organic solvent; the reference compound includes 5-hydroxymethylfurfural and 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside. The reference solution was subjected to high performance liquid chromatography to obtain a reference chromatogram, and the chromatogram of the test sample and the reference chromatogram were compared. The conditions for the high-performance liquid chromatography detection include: Mobile phase A is acetonitrile, and mobile phase B is an aqueous solution of phosphoric acid, wherein the volume percentage of phosphoric acid in the aqueous solution is 0.08-0.12%; the flow rate is 0.85 mL / min-0.95 mL / min; gradient elution is used; The gradient elution procedure includes: From 0 to 25 minutes, the volume percentage of the mobile phase A is maintained at 3%. Between 25 and 40 minutes, the volume percentage of mobile phase A increased from 3% to 11%. From 40 min to 85 min, the volume percentage of the mobile phase A increased from 11% to 15%. Between 85 and 110 minutes, the volume percentage of the mobile phase A increased from 15% to 18%.
Citation Information
Patent Citations
Kidney invigorating blood tonifying particle and its production method
CN1689610A
